NK Cell Therapy for Malignant Solid Brain Tumors

NCT07552233 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Malignant Solid Brain Tumors
Glioblastoma (GBM)
Glioblastoma Multiforme (GBM)
Brain Metastasis
Malignant Meningioma

Interventions

DRUG: Autologous NK cells

Sponsor

Peking University Third Hospital

Collaborators

[object Object]
[object Object]
[object Object]